Clinical trial
A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects…
NCT00220337 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00220337 |
|---|---|
| Title | A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy |
| Official title | A Multicenter, Open-label Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy |
| Lead sponsor | UCB Pharma, Industry |
| Collaborators | SCHWARZ BIOSCIENCES GmbH - Part of UCB Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Painful Diabetic Neuropathy |
| Intervention type | Drug |
| Interventions | Lacosamide |
| Enrollment | 371 |
| Start date | Dec 21, 2004 |
| Primary completion | Oct 31, 2007 |
| Completion | Oct 31, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 24, 2023 |
| Countries | Germany |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: